Peripheral blood marker changes predict response and prognosis in locally advanced gastric cancer with neoadjuvant sintilimab plus XELOX

doi:10.4251/wjgo.122796

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(17)

(0)

(47)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Oct 15, 2026; 18(10): 122796
Published online Oct 15, 2026. doi: 10.4251/wjgo.122796

Table 4 Multivariate logistic regression analysis of predictors of treatment response

	OR	P value	95%CI
cT stage (cT₄ vs cT₃)	0.425	0.283	0.089-2.028
Histological type (non-PC vs PC)	8.522	0.036	1.146-63.374
Post-treatment MLR	2.479	0.035	1.064-5.788

OR: Odds ratio; CI: Confidence interval; PC: Poorly cohesive gastric adenocarcinoma; MLR: Monocyte-to-lymphocyte ratio.

Full Size Table

Citation: Wu Y, Xu MM, Wang GL, Du WD, Su XH. Peripheral blood marker changes predict response and prognosis in locally advanced gastric cancer with neoadjuvant sintilimab plus XELOX. World J Gastrointest Oncol 2026; 18(10): 122796
URL: https://www.wjgnet.com/1948-5204/full/v18/i10/122796.htm
DOI: https://dx.doi.org/10.4251/wjgo.122796

Wu Y, Xu MM, Wang GL, Du WD, Su XH. Peripheral blood marker changes predict response and prognosis in locally advanced gastric cancer with neoadjuvant sintilimab plus XELOX. World J Gastrointest Oncol 2026; 18(10): 122796 [DOI: 10.4251/wjgo.122796]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.